Image
Back to top
Prof Thrasyvoulos Tzellos
Dermatologist
Professor Thrasyvoulos Tzellos is Dermatologist at the Department of Dermatology, NLSH Bodø, Norway, and Associate Professor at Institute of Clinical Medicine, University of Tromsø, Norway.
Professor Tzellos received his medical degree from the Aristotle University of Thessaloniki, Greece, moving on to complete an MSc in Clinical Research and Epidemiology and a PhD from the same institution. He has also completed several postgraduate courses on educational techniques, epidemiology and clinical pharmacology in healthcare.
He has published over 100 peer-reviewed articles and his current research expertise lies in the field of evidence-based medicine, clinical trials, meta-analyses, case-control studies, cohort studies and large-scale epidemiological studies. He is actively involved in clinical research on hidradenitis suppurativa and is a founding member of the European Hidradenitis Suppurativa Foundation (EHSF).
0 resources
Infographic2 minutes read
Explore which treatment targets may be more appropriate for making treatment decisions in axSpA.
EU-DA-2400658
Infographic2 minutes read
PsA and axSpA have overlapping disease manifestations which are driven by inflammation.1 Explore several extracellular cytokines that are implicated in these...
EU-DA-2400655
Video2 minutes watch
Watch Prof Frank Behrens discuss the importance of treating skin symptoms in addition to musculoskeletal symptoms for patients with SpA.
EU-DA-2400671
Video3 minutes watch
Achieving ACR50 is associated with improvements in quality of life for patients with PsA.1 Dive into the data supporting higher treatment targets in clinical...
EU-DA-2400650
Video3 minutes watch
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
EU-DA-2400669
Video2 minutes watch
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...
EU-DA-2400668